Latest papers

Mumps epidemiology in the mid-west of Ireland 2004-2008: increasing disease burden in the university/college setting.

Does primary immunisation status predict MMR uptake?

Mumps epidemiology and immunity: the anatomy of a modern epidemic.

Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.

Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains

Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.

Immunogenicity and safety of a novel formalin-inactivated and alum-adjuvanted candidate subunit vaccine for mumps.

Mumps in the United States.

Update on universal childhood immunizations.

Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students--Iowa, 2006.

Increased mumps incidence in the Netherlands: review on the possible role of vaccine strain and genotype.

Immune responses to mumps vaccine in adults who were vaccinated in childhood.

Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Who cares about mumps? You should!

Mumps vaccine performance among university students during a mumps outbreak.

Recent resurgence of mumps in the United States.

Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study.

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.

Mumps.

[Evolution of serologically confirmed cases of mumps in the Madrid community, Spain, during a period of 7 years (2000--2006)].